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INTroDuCTIoN
Mastitis is defined as any inflammatory process affecting 
the mammary gland (International Dairy Federation 1987). 
Clinical mastitis (CM) is defined as mastitis causing clinical 
signs in the udder or visible changes in the milk and 
according to the recommendation of the International Dairy 
Federation (IDF), is divided into severe, moderate or mild 
(International Dairy Federation 1999). In the Norwegian 
recording system, moderate and severe CM is reported 
using the same health code: 303 (Østerås et al. 2007). 
Subclinical mastitis is only detected by laboratory methods 
such as the analysis of somatic cell count (SCC) or other 
parameters related to the inflammatory process.
The main motivation for mastitis control is an economic 
one as stated by Morris (1975). Little scientific work has 
concentrated on the subject of economics and mastitis, 
although the IDF has tried to summarise its relevance 
(International Dairy Federation 2005). The subject was also 
discussed in a recently published review paper (Halasa 
et al. 2007). The data revealed a large variation in the 
calculated costs and benefits of mastitis and mastitis 
management between the different studies. In addition 
to this, it is clear that important factors were ignored in 
some of the studies. As economic gain is a major goal, 
economic parameters must be included when mastitis 
control programmes are evaluated. In Norway, the costs of 
mastitis are calculated and presented for each farm during 
each recording period (Table 1).
Other important parameters are animal welfare and 
farmer welfare. Most clinical cases of mastitis are painful 
for the effected animal and create a lot of work for the 
farmer. Subclinical mastitis may also be painful for the 
cow (Eshraghi et al. 1999). Mastitis causes changes 
in milk content and characteristics such as shelf life 
ABSTrACT
This paper describes the methods and results of the Norwegian Mastitis Control Program implemented in 1982. The program has formed 
an integral part of the Norwegian Cattle Health Services (NCHS) since 1995. The NCHS also have specific programs for milk fever, 
ketosis, reproduction and calf diseases. The goal of the program is to improve udder health by keeping the bulk milk somatic cell count 
(BMSCC) low, to reduce the use of antibiotics, to keep the cost of mastitis low at herd level and improve the consumers’ attitude to milk 
products. In 1996, a decision was made to reduce the use of antibiotics in all animal production enterprises in Norway by 25% within 
five years. Relevant data has been collected through the Norwegian Cattle Herd Recording System (NCHRS); including health records 
since 1975 and somatic cell count (SCC) data since 1980. These data have been integrated within the NCHRS. Since 2000, mastitis 
laboratory data have also been included in the NCHRS. Data on clinical disease, SCC and mastitis bacteriology have been presented to 
farmers and advisors in monthly health periodicals since 1996, and on the internet since 2005. In 1996, Norwegian recommendations 
on the treatment of mastitis were implemented. Optimal milking protocols and milking machine function have been emphasised and less 
emphasis has been placed on dry cow therapy. A selective dry cow therapy program (SDCTP) was implemented in 2006, and is still being 
implemented in new areas. Research demonstrates that the rate of clinical mastitis could be reduced by 15% after implementing SDCTP. 
The results so far show a 60% reduction in the clinical treatment of mastitis between 1994 and 2007, a reduction in BMSCC from 
250,000 cells/ml to 114,000 cells/ml, and a total reduction in the mastitis cost from 0.23 NOK to 0.13 NOK per litre of milk delivered 
to the processors, corresponding to a fall from 9.2% to 1.7% of the milk price, respectively. This reduction is attributed to changes in 
attitude and breeding, eradicating bovine virus diarrhoea virus (BVDV) and a better implementation of mastitis prevention programmes.
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and properties for cheese processing (Ma et al. 2000). 
Therefore, dairy processors offer quality payments for 
a low content of inflammatory parameters in the milk 
(e.g. SCC). The absence of careful mastitis control, for 
example when aiming only at reducing the SCC, might 
lead to huge costs of extra treatment and culling at farm 
level. Economic analysis should therefore include all of 
the important issues in mastitis control, for example milk 
quality, production loss, discarded milk, treatment and 
replacement cost etc.. Other goals are to minimise the risk 
of producing milk being contaminated with pathogens or 
toxins that are a hazard to human health (Streptococcus 
agalactiae, Staphylococcus aureus toxins, Listeria spp. 
etc.) and to eliminate, as far as is possible, specific highly 
pathogenic strains of bacteria, or bacteria that are carriers 
of resistance genes. The presence of these bacteria has 
demanded a continuous need for new and sophisticated 
antibiotics and they might cause transfer of pathogens or 
resistance genes into the human food chain, which may 
influence consumer attitude towards milk (Østerås et al. 
2006a). 
As most pathogens involved in mastitis are common in the 
dairy cow environment, it is not economically feasible to 
try to eradicate mastitis. Pathogens like Mycoplasma bovis 
and Streptococcus agalactiae are not usually found in the 
environment of the cow and would be easier to eradicate. 
Mastitis could, however, be controlled more successfully 
than is currently being achieved. 
A full-scale mastitis control programme has to include 
information on the prevalence of the pathogen to be 
controlled. The pathogen involved must be recognised to 
know how best to control its spread and pathogeneses. 
Exact knowledge should be based on unbiased research. 
Finally, there is a need for personnel and resources to 
provide information and carry out advisery work. Motivation 
is also vital to encourage and assist the farmer or herds-
person to make the correct decision at the correct time. 
The aim of this paper is to describe the methods and 
results of the Norwegian Mastitis Control Programme 
implemented in 1982. 
mATerIAlS	AND	meTHoDS
Records of mastitis at quarter level
Mastitis diagnosis is achieved by the recognition of clinical 
signs by farmers and /or veterinarians, supplemented 
by cow-side tests like the Californian Mastitis Test 
(CMT), and supplemented with bacteriological tests like 
Limulus (Waage et al. 1994) and/or culturing on different 
agars such as SELMA or SELMA PLUS (SVA, 2008). Our 
experience is that this is costly and gives little useful 
information without knowledge of the total health status 
at cow or herd level. Our aim is to accumulate useful 
information over time, and to use it at herd level to 
reveal which pathogen is involved in a particular herd 
in clinical as well as subclinical cases. The information 
is used to develop a control and treatment programme 
adapted to specific farms and specific pathogens. Since 
1996, such information has therefore been included 
in the NCHRS and presented in the health periodical 
together with information on cow milk somatic cell count 
(CMSCC) and clinical disease (Figure 1). Since 2005, this 
information has also been available on the internet for 
farmers, advisers and veterinarians. This is the reason why 
Norwegian veterinarians have been encouraged to send 
mastitis samples to the authorised mastitis laboratory for 
bacteriological investigation rather than performing this 
investigation themselves.
Records of clinical mastitis
In 1975, Norway introduced a requirement to keep records 
of mastitis treatments (Østerås et al. 2007), probably the 
first country worldwide to do so. Computerised records 
were kept to assist the control of certain reproductive 
disorders and also to assess whether an association 
between breeding for higher milk production and mastitis 
existed. From 1978, focus has been on CM resistance in 
the Norwegian Cattle Breeding Programme (Heringstad et 
al. 2003). Since 1992, there has been greater focus on 
mastitis than on milk yield. All historical records on clinical 
mastitis, CMSCC and milk yield as well as bacteriology are 
Table 1: Example of the costs of mastitis calculated for a farm during the period 2007 to 2008
Herd data Value/unit
A   Herd bulk milk somatic cell count (BMSCC) during the last year 83,000 cells/ml N/A
B   Economic loss in quality payment in NOK with premium quality as the baseline 0 1 NOK
C Production loss due to high BMSCC in litres 0 Litres 2.25 NOK
D   Litres of milk discarded due to mastitis therapy 2,100 Litres 3.60 NOK
E  Number of mastitis cases treated 12 550 NOK
F   Number of cows culled due to udder health 7 3500 NOK
G Mean number of cows in the herd 30.6 N/A
H Amount of milk in litres delivered during the last year 193,238 litres N/A
Total loss in NOK, when multiplying B to F with the unit cost  38,660 NOK
The national mean total udder health loss per litre of delivered milk 0.13 NOK
The herd’s mean total udder health loss per litre of milk produced during the last year 0.20 NOKIrish	Veterinary	Journal	Volume	62	Supplement 28
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now available for analysis at both herd and individual cow 
level. This allows feed-back to farmers and advisers on how 
different environmental changes and treatment protocols 
work on a specific farm.
Records of subclinical mastitis
Subclinical mastitis is recorded as SCC usually either at 
cow (composite) level (as CMSCC) or at bulk tank level 
(as BMSCC). These records became available from the 
late 1970s or early 1980s. From 1975 to 1979/80, 
testing was performed by the mastitis laboratories twice 
a month using a coulter counter. However, since 1980, 
CMSCC has been measured every second month or every 
month and BMSCC four times a month using fossomatic 
(Foss, Hillerød, Denmark). All information was incorporated 
into the NDHRS (Figure 1). The most important result of 
this is that the information on consecutive analyses is 
mathematically transformed to geometric means, sorted 
according to importance, and presented in a more useful 
format so the data can be used directly in the herd and at 
cow level for analyses in a problem solving process as well 
as for prognostics and diagnostics at cow level. Use of the
internet makes these data available within a few seconds. 
Data can be accessed detailing animal identity, parity and 
history of individual cow somatic cell counts; results from 
bacteriology sampling; as well as key fertility, health and 
treatment data.
The usage of information
At cow level, information on diagnostics can be used to 
predict the prognosis both pre- and post-treatment for 
different cows within a herd, according to expected cure 
rates after therapy or no therapy, and hence to select 
cows for bacteriological culturing of milk samples to 
add more information to the system. Cows can then be 
selected for dry cow therapy, culling at the optimal lactation 
stage, breeding etc. (Østerås et al. 1999b). Finally, the 
information can be used to identify milk to be discarded 
from high SCC cows for delivery to the dairy processor. 
The importance of such selection to keep the BMSCC low 
is demonstrated by Østerås (2002). CMSCC together with 
available bacteriology is thus the most important decision-
making tool in the daily dairy herd management of mastitis.
At herd level the information can be used to analyse herd 
characteristics, for example new infection rate, incidence 
of clinical cases, duration, prevalence etc. (Table 2) and the 
economic impact of mastitis in that herd. Intervention can 
be made as early as possible based on this information to 
avoid further financial loss.
The Norwegian Action Plan for mastitis control
Norwegian mastitis control has followed the main principles 
stated by Dodd (1980) and Morris (1975). An effective 
mastitis control programmeme should aim to reduce the 
new infection rate. Morris (1975) questioned the use of 
introducing a duration of infection criterion as suggested 
by Dodd (1980). Morris (1975) argued that although the 
term duration is easily comprehended, it is very difficult 
and time-consuming to measure in a significant population 
of animals. With new computer technology, the Norwegian 
recording system is calculating both the new infection rate 
based on CMSCC and CM records as well as the duration 
during the last 12 months, during each reporting period (12 
months) for each herd. The 
variables are described in more 
detail by Valde et al. (2005). 
The duration is simplified 
according to Dodd’s equation; 
the prevalence equals the 
new infection rate multiplied 
by the duration. An example 
of a report with prevalence, 
new infection rate and duration 
is presented in Table 2. The 
programme will be adapted to 
the figures of new infection 
rate or duration. If the new 
infection rate is relatively high, 
more emphasis will be put on 
correction of the environmental 
management and the milking 
protocols. If duration is 
relatively high, more emphasis 
will be placed on therapy or 
culling.
Some examples of risk factors 
to be taken care of under the 
Norwegian action plan for 
mastitis control are as follows:
Paper
Periodicals
EDB
Internet
EDB Business Partner 
Norway AS SDB
IRS
ODB
LDB
Advisors
Vets
Farmer
via paper
Dairy Advisor
via internet
DHI/health
Dairy Farm
N=12,740
N=5,962
(47%)
N=6,778
N=9,575 (75%)
A.I. Meat Milk(i) Milk(h) Mastitis
Farmer
via internet GENO Slaught.
house
Dairy
Lab.
Mastitis
Lab.
TINE BA
Dairy Association
Figure 2: Data flow-chart illustrating the integration of all relevant information in the Norwegian Dairy Herd Recording 
System (NDHRS). DHI/health = Dairy herd improvement system including health records; AI = artificial insemination; 
Geno = Geno breeding and AI association, Norway; Milk(i) = Individual milk samples within NDHRS; Milk(h)= herd bulk 
milk samples within dairy processors; SDB = Dairy Cattle Data Base; ODB = Bull (Ox) Data Base; LDB = Delivery Milk 
Data Base; IRS = Official Individual Record System; TINE BA = TINE BA Norwegian Dairy Association. N indicates number 
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1. Avoid high new infection rate
  a. Proper and exact environmental action according to  
    the pathogens and problems present:
    i.  Good milking routines:
        1. Cleaning (hygiene);
        2. Good interaction with the cows (let down and  
          welfare);
        3. Proper handling and milking equipment (air  
          inlet);
        4. Good and proper preparation (let down   
          and welfare); and,
        5. Careful removal of clusters (air inlet and  
          over milking).
    ii. Good functioning milking machine:
        1. Proper vacuum condition (teat handling);
        2. Proper liners (teat handling, impacts);
        3. Proper pulsation (teat handling);
        4. Vacuum capacity (teat handling, impacts);  
          and,
        5. Proper capacity, dimension and slope of  
          pipelines (impacts).
    iii.  Good environment:
        1. Clean (hygiene and management);
        2. Dry (hygiene, management and building);
        3. Good stall function (animal welfare, hygiene);  
          and,
        4. Proper bedding area (animal welfare, hygiene).
    iv. Diminish contact between the pathogen reservoir  
      and the teat canal:
        1. Culling chronically infected cows    
          (management);
        2. Clean and dry environment (management,  
          building);
        3. Avoid bedding material that acts as reservoir  
          for pathogens (hygiene, management); and,
        4. Avoiding buying animals from other herds,  
          or careful screening of health status in their  
          herd of origin (bio-security).
2. Shortening the duration of existing infections:
  a. Removal of udder pathogen reservoir:
    i.  Culling chronically infected cows (S. aureus and  
      others);
    ii. Clean and dry environment (Coagulase negative 
      staphylococci (CNS) and other environmental 
      pathogens); and,
    iii.  Therapy at an appropriate time and of the correct  
      cows (dry cow period, S. aureus and Streptococci).
  b. Establish a treatment protocol adapted to the relevant  
    pathogen and environment:
    i.  Selective dry cow therapy (for expected    
      responders);
    ii. Appropriate therapy of clinical cases (for expected  
      responders as well as necessary to ensure animal  
      welfare);
    iii.  Appropriate detection and therapy of subclinical  
      cases during lactation (for those with economic  
      benefits – very few cases); and,
    iv. Segregation (for unpromising cases until    
      slaughtered).
All points should refer to the actual pathogen present on 
the farm being considered. This means, you must know the 
pathogen(s) involved in the mastitis problem, both at herd 
level as well as at regional and national level. Pathogens 
involved may be different from herd to herd and from 
country to country, and may change over time (Pitkala et 
al. 2004). This is probably caused by changes in the cow’s 
environment and treatment pressure. 
Regional and national level 
In Norway a survey carried out during the year 2000 
(Østerås et al. 2006b) gave highly relevant information 
for the implementation of new strategies. Staphylococcus 
aureus is the most prevalent mastitis pathogen. However, 
half of the isolates were associated with fairly low CMSCC 
and the incidence of CM was only slightly increased in cows 
infected with Staphylococcus aureus (Reksen et al. 2006). 
Milk yield was higher just after calving, but reduced later in 
lactation (Reksen et al. 2007). The prevalence was highest 
at the start of the first parity and lowest in the second 
parity. The prevalence of Staphylococcus aureus decreased 
during lactation while Streptococcus dysgalactiae 
increased. There was also a strong seasonal effect, with 
a higher prevalence during the late indoor season and 
the summer compared with the autumn (Østerås et al. 
2006b). The survey illustrated the importance of good 
information before implementing a control programme. The 
control programme will have to be changed over time, and 
also has to be different from country to country because 
Table 2: Example of estimated herd characteristics presented on the herd 
periodical each month when somatic cell count is analysed.
Health status in the herd  Herd  Country 
Number of cell count recordings during the 
period. 
8  6 
Prevalence of SCC > 200,000 cells/ml (%).  24  19 
New inflammation > 200,000 cells/ml (%) 
(corrected to 6 analyses).
72 ( 65)  53 
Duration estimated in months (corrected to 6 
samples).
4.3 ( 4.8)  4.7 
Mastitis – number of cases per cow-year.  0.05  0.27 
Ketosis – number of treatments per cow-year.  0.00  0.06 
Milk fever – number of treatments per calving 
after 1st parity. 
0.13  0.08 
Reproduction treatments –number of treatments 
per cow-year. 
0.09  0.11 
Standardised reproduction number (FS) 
(country=county). 
82  64 
Calves < 6 months – number of treatments per 
half-year.  
0.10  0.02 Irish	Veterinary	Journal	Volume	62	Supplement 30
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of differences in cow management and the prevalence 
of the various pathogens. Under Norwegian conditions, 
much more focus than before should be put on heifer 
environment, as well as feeding around and before calving. 
Appropriate risk factors are highlighted in papers by Valde 
et al. (2007) and Waage et al. (1998).
Breeding programme for resistance
Research has documented that it is possible to breed for 
a higher resistance to mastitis (Heringstad et al. 2005). 
Heritability is found to be 3-5% for CM and approximately 
15% for SCC. Many countries have included SCC in 
the breeding index, but Norway has only included CM. 
To achieve progress with traits of low heritability, it is 
important to work with large daughter groups which 
provide more precision in the selection of bulls, despite a 
low heritability of the trait. As there is a negative genetic 
correlation between CM and milk yield, sufficient weight 
has to be put on mastitis to get a positive effect. The 
Norwegian breeding programme is probably the only 
programme to have placed sufficient weight on CM to 
get a net positive effect reducing mastitis incidence 
in the population. The Norwegian breeding programme 
aiming towards a higher individual resistance against 
CM is an integrated part of the Norwegian mastitis 
control programme. Some pathogens are more likely to 
cause clinical signs of mastitis  (Escherichia coli), while 
other pathogens usually cause subclinical infections (S. 
aureus and CNS). New research comparing two selective 
genetic lines of cattle, one for high yield and one for high 
resistance against CM illustrate a large selective effect 
with a difference of 10% in CM after only five generations 
(Heringstad et al. 2007).
Other diseases
There is a significant correlation between selected other 
diseases and mastitis. This means that the control of 
mastitis can be even more effective if relevant diseases 
are included in the control programme for e.g., BVDV, milk 
fever, reproductive disease and ketosis. It is documented 
that a herd newly infected with BVD virus suffered a 7% 
increase in the risk of CM due to the effect on the immune 
system during the infectious stage of the disease (Waage 
2000). When starting the BVD eradication programme in 
Norway in 1992, the prevalence of BVD was 26% of herds 
being sero-positive on bulk milk tank samples. In 2004, 
there were only three herds still under restriction, due to 
possible infected animals. The last animals persistently 
infected with BVD virus were slaughtered during summer 
2006. The entire Norwegian cattle population has been 
tested and known to be free from BVD virus since. This has 
had a positive effect on the results of the mastitis control 
programme. 
Dry cow therapy and teat dipping
The Norwegian mastitis control programme is different 
from the five point plan as there has been very little dry 
cow therapy and only approximately 12% of the herds 
have practised regular teat dipping. Reasons for this 
are that dry cow therapy was almost ‘banned’ from the 
Norwegian School of Veterinary Science in the 1960s and 
1970s. Selective dry cow therapy has been implemented 
since 2005 using the information system in the selection 
process. All cows with more than 100,000 cells/ml 
CMSCC during the last three samples before drying off are 
recommended to be selected for bacteriological testing. 
Those which are positive for S. aureus, S. dysgalactiae or 
other major pathogens should receive dry cow treatment. 
No treatment is recommended if CNS is identified.  Cows 
with high CMSCC (above 600-700,000 cells/ml) and with 
major pathogens should be culled at the most economically 
advantageous time during their lactation. The programme is 
scientifically based on the estimated probability of success 
or failure according to Østerås et al. (1999a, 1999b), 
Østerås and Edge (2000), and Whist et al. (2006, 2007). 
At present about 0.05% of Norwegian cows receive dry cow 
therapy. According to our data, approximately 35% should 
be sampled and of those 35-40% should be assessed for 
dry cow therapy. There is, therefore, a need for dry cow 
therapy in approximately 10% of Norwegian cows. The 
latest dry cow therapy programme has documented that 
this will contribute to a further 15% decrease in CM (Whist 
et al. 2006).
The limited use of teat dipping is due to the traditional 
way of thinking in Norway; that teat dipping would be 
detrimental to minor pathogens and normal commensally 
skin bacteria and hence ease the colonisation by 
pathogens like S. aureus. Results from a large project in 
164 herds on evaluating the effect of teat dipping, showed 
no effect on the incidence of S. aureus. infections although 
a significant reduction in S. dysgalactiae infections was 
seen (Whist et al. 2007). 
reSulTS
The results of the Norwegian mastitis control programme 
are illustrated in Figure 2 and Figure 3. There has been 
progress in reducing BMSCC between 1980 and 2002, and 
thereafter a slight increase. CM has decreased since 1994. 
Since 1985, the BMSCC has fallen, but clinical cases 
increased until 1994. Figure 4 illustrates that the economic 
loss due to mastitis in Norway decreased between 1991 
and 2004. The main reason for this is reduced loss due to 
CM and reduced production losses. The rate of CM can be 
reduced further so long as the production and replacement 
loss does not increase. This will be followed closely and is 
an important part of the management of mastitis control in 
the country and regions.
The survey in the year 2000 identified the cow level 
prevalence to be 22.2% for S. aureus, 2.8% for penicillin 
G resistant S. aureus, 3.8% for S. dysgalactiae, 0.0% for 
S. agalactiae, 5.7% for CNS and 8.8% dry quarters. Thus, 
the proportional rate of S. aureus showing resistance to 
penicillin G has risen from 10.5 to 12.6%.
For samples taken from CM cases, we typically find 49.8 
% of cows with S. aureus, 4.1% with penicillin G resistant 
S. aureus, 17.3% with S. dysgalactiae, 6.4% with coliforms Irish	Veterinary	Journal	Volume	62	Supplement
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and 7.7% with CNS. The same 
prevalence at quarter level is 
16.6 to 22.8 %, 1.2 to 1.6 %, 
4.2 to 6.3%, 1.6 to 2.0% and 1.8 
to 2.8% respectively, depending 
on quarter site. The proportional 
rate of penicillin-resistant S. 
aureus is 8.2% at cow level and 
approximately 7% at quarter 
level.
Figure 4 illustrates that the 
economic benefit of this work 
has a value of 0.10 NOK per 
litre of milk delivered to the 
dairy. In Norway this comprises 
a total of 150 million NOK, or 
approximately 40% of the level 
in early 1990’s. More detailed 
analyses of the economic 
benefit of the control programme 
illustrates that of the total benefit 
between 1990 and 1994 was 
only 17 million NOK. Of these 
eight million NOK was generated 
from payment for improved milk 
quality and 24 million NOK from 
reduced production loss related 
to lower SCC but an extra loss of 
11 million NOK from increased 
clinical treatments (both 
veterinary fees and discarded 
milk) and finally another extra 
loss of four million NOK from 
increased replacement rates 
due to mastitis. Between 1994 
and 2004, after the change in 
treatment strategy, the total 
gain achieved as a result of 
implementing the mastitis 
reduction programme was 173 
million NOK. Two million NOK 
was generated from better 
quality payment, 55 million 
NOK from reduced production 
losses related to lower SCC, 106 
million NOK from fewer clinical 
treatments (both veterinary 
fees and discarded milk) and 
finally 10 million NOK from 
reduced replacement rates as 
a consequence of mastitis. It 
is obvious that the treatment 
strategy implemented to lower 
the BMSCC during the 1980s 
was counter-productive from 
an economic point of view, as 
the extra treatment and culling 
costs negated much of the gain 
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Figure 3: The bulk milk somatic cell count (BMSCC) in Norway from 1980 to 2007 expressed as both arithmetic and 
geometric mean.
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Figure 4: Estimated total loss from mastitis in Norway from 1988 to 2004 divided according to type of loss and in total 
øre (NOK/100) per litre of milk delivered to the dairy processor.  A computation system shift was made in the year 
2000 indicated with open space and a higher level in the year 2000 compared to 1999. The blue line indicates loss 
per litre, bars indicate total loss divided by loss due to quality (lost premium), production loss, clinical mastitis, and 
replacement cost.
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Figure 2: The incidence rate per cow-year of a cow being treated for all types of clinical mastitis, severe/moderate 
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achieved from the large improvement in BMSCC. The new 
strategy, implemented in 1994, has been successful in 
reducing the treatment cost of more than 100 million NOK, 
without any adverse effect on milk quality or BMSCC.
DISCuSSIoN	AND	CoNCluSIoN
The Norwegian mastitis control programme has resulted 
in significant progress and the extra money earned has 
been approximately 200 million NOK since 1994. The 
main reason for the progress is probably the presence of 
well-organised co-operatives, which have made it possible 
to collect all relevant information into one database. 
The data is easily accessed by the farmer, the breeding 
organisation and by university researchers. The data has 
recently become more easily available for local advisers 
and veterinarians through the internet. 
Since 1984 there has been a large improvement in BMSCC 
in Norway. However, there has also been a large increase 
in the number of clinical cases of mastitis treated. This 
has probably been due to more treatment administered 
to subclinically infected cows to lower the BMSCC to 
achieve quality targets for additional payments. This 
led to over-treatment and excessive cost. To avoid this, 
treatment protocols for mastitis therapy were introduced 
during 1995/96. This involved a more restrictive use of 
antibiotics, especially during lactation. Instead of treating 
S. aureus infected cows immediately, subclinical infections 
were only treated at drying off. In addition, cows with 
high SCC that are judged as non-responders to therapy 
are assessed for culling. This part of the programme will 
dramatically reduce the prevalence of chronically infected 
cows, which also are risk factors for the development of 
penicillin resistant bacteria (Østerås et al. 1999a).
The health periodical presented to farmers and advisers 
is the key tool at herd level to formulate the correct 
control programme. The new infection rate, duration and 
prevalence, as well as economic estimates of total mastitis 
losses in NOK per litre of milk delivered, is presented every 
second month to avoid over-treating cows and also to avoid 
excessively intensive culling strategies. 
The strategy for reducing antibiotic use by 25% in five years 
had three main goals: 
1)   To change the attitude of farmers, advisers and 
veterinarians to avoid uneconomic therapy of 
subclinical and mild cases of mastitis (short term 
effect); 
2)   To make progress with optimal mastitis control 
protocols (medium term effect); and,
 3)  To breed for resistance to mastitis and to improve the 
cow’s ability to cope with mastitis (long term effect). 
These goals were achieved within three years and after 
ten years there has been more than a 50% decrease in 
mastitis in Norwegian dairy herds. 
Heringstad et al. (2005) illustrate that the genetic 
improvement of Norwegian cattle has been 3% per unit 
in 10 years. This means that of 0.15 (decrease from 
0.35 to 0.20), 0.03 can be attributed to the effect of the 
breeding programme. This is 20% of the total reduction 
of 173 million NOK, or 35 million NOK. A BVDV infected 
herd will show a 7% increase in the loss due to mastitis 
due to the introduction of BVDV (Waage 2000). Twenty-five 
per cent of Norwegian herds were infected with BVDV in 
1994 compared to none in 2004. BVDV control contributed 
three million NOK and the remaining 135 million NOK (173 
minus 38) was associated with attitude changes, improved 
treatment strategies and better mastitis control due to a 
better information system. 
Information technology involving co-ordinated data and 
modern epidemiological research is an important tool when 
trying to control mastitis. The constraint now in Norway 
is to teach farmers, veterinarians and advisers to use all 
of the available information in the correct way. One main 
goal is to implement selective dry cow therapy throughout 
the country. By treating only 9% of the cows, and culling 
chronically infected cows with a high SCC, the incidence 
of CM is expected to be reduced by an additional 15% 
(Whist et al. 2006). Research from the Norwegian breeding 
programme has proven that selective breeding for mastitis 
resistance is beneficial. Research has even shown that 
putting maximum weight on resistance to CM could reduce 
CM by another 10% per unit within five cow generations 
(Heringstad et al. 2007).
Mastitis has to be included as a part of total herd health 
management. There are relations between different 
diseases. However, the same risk factors might have 
different influences on different diseases.
Finally it is the farmers’ responsibility to implement a 
control programme and this demands motivation. New 
research from Norway illustrates that there should be 
put more emphasis placed on heifer environment (Waage 
et al. 1998) as well as feeding strategy around and 
before calving (Valde et al. 2007). Teat dipping should be 
implemented in herds with S. dysgalactiae problems, but 
not in herds infected with S. aureus (Whist et al. 2007). 
Good mastitis control depends on good management 
practices at farm level, which have to be run by the farmer.
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